Sorrento Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Sorrento Therapeutics, Inc.(2.6%)
2023/10/05 17:22 (美东)
Sorrento Therapeutics | 4:持股变动声明-股东 Sorrento Therapeutics, Inc.
2023/10/05 17:16 (美东)
Sorrento Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Sorrento Therapeutics, Inc.(1.3%)
2023/09/26 16:49 (美东)
Sorrento Therapeutics | 4:持股变动声明-股东 Sorrento Therapeutics, Inc.
2023/09/25 16:27 (美东)
Sorrento Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Sorrento Therapeutics, Inc.(43.3%)
2023/08/14 20:59 (美东)
Sorrento Therapeutics | 4:持股变动声明-高管 Ji Henry
2023/03/20 19:52 (美东)
Sorrento Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(0.03%)
2023/03/10 11:21 (美东)
Sorrento Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(0.0%)
2023/03/08 14:19 (美东)
Sorrento Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Sorrento Therapeutics, Inc.(44.2%)
2023/03/03 09:10 (美东)
Sorrento Therapeutics | SC 13G:超过5%持股股东披露文件-Millennium Management LLC(3.1%),Millennium Group Management LLC(3.1%)等
2023/02/17 16:07 (美东)
Sorrento Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(10.73%),SSGA FUNDS MANAGEMENT, INC.(8.78%)
2023/02/09 15:48 (美东)
Sorrento Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(6.26%)
2023/02/09 11:32 (美东)
Sorrento Therapeutics | 5:权益变更年度报表-董事 Janda Kim
2023/02/06 21:10 (美东)
Sorrento Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(8.4%)
2023/02/03 16:27 (美东)
Sorrento Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Sorrento Therapeutics, Inc.(45.5%)
2023/01/23 16:33 (美东)
Sorrento Therapeutics | 4:持股变动声明
2023/01/23 16:11 (美东)
Sorrento Therapeutics | 4:持股变动声明
2022/12/23 14:28 (美东)
Sorrento Therapeutics | 4:持股变动声明
2022/12/16 20:10 (美东)
Sorrento Therapeutics | 4:持股变动声明
2022/12/02 19:21 (美东)
Sorrento Therapeutics | 4:持股变动声明
2022/11/25 15:21 (美东)
暂无数据
暂无数据